JPS5855421A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPS5855421A
JPS5855421A JP57153790A JP15379082A JPS5855421A JP S5855421 A JPS5855421 A JP S5855421A JP 57153790 A JP57153790 A JP 57153790A JP 15379082 A JP15379082 A JP 15379082A JP S5855421 A JPS5855421 A JP S5855421A
Authority
JP
Japan
Prior art keywords
methanol
phenoxy
methyl
propyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57153790A
Other languages
English (en)
Japanese (ja)
Inventor
ロイ・ト−マス・ブリツテン
バリ−・ジヨン・プライス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPS5855421A publication Critical patent/JPS5855421A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP57153790A 1981-09-04 1982-09-03 医薬組成物 Pending JPS5855421A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04
GB26787 1981-09-04

Publications (1)

Publication Number Publication Date
JPS5855421A true JPS5855421A (ja) 1983-04-01

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57153790A Pending JPS5855421A (ja) 1981-09-04 1982-09-03 医薬組成物

Country Status (18)

Country Link
JP (1) JPS5855421A (fr)
KR (1) KR840001276A (fr)
AU (1) AU8799882A (fr)
BE (1) BE894286A (fr)
DE (1) DE3232831A1 (fr)
DK (1) DK396582A (fr)
FI (1) FI823041L (fr)
FR (1) FR2512343A1 (fr)
GB (1) GB2105588B (fr)
GR (1) GR76433B (fr)
IL (1) IL66709A0 (fr)
IT (1) IT8249072A0 (fr)
LU (1) LU84364A1 (fr)
NL (1) NL8203456A (fr)
PT (1) PT75504A (fr)
SE (1) SE8205035L (fr)
ZA (1) ZA826479B (fr)
ZW (1) ZW18582A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064441A1 (fr) * 2008-12-04 2010-06-10 株式会社ネクスト21 Agent d’atténuation de trouble de muqueuse gastro-intestinale induit par des nsaid et procédé de fabrication de celui-ci

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193009A (en) * 1979-03-02 1983-07-15 Glaxo Group Ltd 3-n-(( -aminoalkyl)(furyl thiophenyl or phenyl)(alkyl))-amino-1h-1,2,4-triazoles
GB2063874B (en) * 1979-10-22 1983-09-28 Glaxo Group Ltd Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064441A1 (fr) * 2008-12-04 2010-06-10 株式会社ネクスト21 Agent d’atténuation de trouble de muqueuse gastro-intestinale induit par des nsaid et procédé de fabrication de celui-ci
CN102238964A (zh) * 2008-12-04 2011-11-09 21世纪国际新技术株式会社 NSAIDs诱因消化道粘膜损伤抑制剂及其制造方法

Also Published As

Publication number Publication date
FI823041L (fi) 1983-03-05
ZA826479B (en) 1984-04-25
DE3232831A1 (de) 1983-03-24
SE8205035D0 (sv) 1982-09-03
LU84364A1 (fr) 1984-04-24
FR2512343A1 (fr) 1983-03-11
FI823041A0 (fi) 1982-09-03
IL66709A0 (en) 1982-12-31
GB2105588B (en) 1984-07-18
GB2105588A (en) 1983-03-30
IT8249072A0 (it) 1982-09-03
PT75504A (en) 1982-10-01
GR76433B (fr) 1984-08-10
NL8203456A (nl) 1983-04-05
KR840001276A (ko) 1984-04-30
AU8799882A (en) 1983-03-10
ZW18582A1 (en) 1984-03-28
BE894286A (fr) 1983-03-02
SE8205035L (sv) 1983-03-05
DK396582A (da) 1983-03-05

Similar Documents

Publication Publication Date Title
US5859060A (en) Timed release tablet comprising naproxen and pseudoepherine
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
JPS63198623A (ja) 医薬組成物
IE51549B1 (en) Solid medicament formulations containing nifedipine,and processes for their preparation
GB2105193A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
JPH06502854A (ja) 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
CZ287558B6 (en) Pharmaceutical preparation
CA2211325A1 (fr) Preparation de clonidine a liberation prolongee
JP2006515299A5 (fr)
JPS6357405B2 (fr)
HU186855B (en) Process for producing galenic pharmaceutical compositions with controlled solving-out of active agents
JPS5896036A (ja) 新ナフタレン誘導体の製法
JPS5855421A (ja) 医薬組成物
EP0109281A1 (fr) Compositions contenant du flurbiprofen ou de l'ibuprofen
JPS6191124A (ja) 抗炎症組成物
JPH0140009B2 (fr)
CA1307739C (fr) Compositions anti-inflammatoires
JP2001511168A (ja) 偏頭痛の治療のためのイブプロフェンおよびドンペリドンを含有する製薬組成物
JP3982889B2 (ja) イブプロフェン含有医薬製剤
JPS63270624A (ja) ニコランジル安定化製剤の製造方法
EP0012621B1 (fr) Composition analgésique contenant de l'acétaminophène comme agent potentialisateur
JPS5865215A (ja) 医薬組成物
KR101801064B1 (ko) 위장질환 치료용 삼중층 정제
GB2216413A (en) Medicaments containing sufotidine
JP2014012660A (ja) ロキソプロフェン含有医薬組成物